218 related articles for article (PubMed ID: 11137745)
1. Surplus value of eosinophil count and ECP to diagnose and monitor asthmatic patients.
Pronk-Admiraal CJ; Haitjema T; Horikx P; Bartels PC
Neth J Med; 2001 Jan; 58(1):9-17. PubMed ID: 11137745
[TBL] [Abstract][Full Text] [Related]
2. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma.
Niimi A; Amitani R; Suzuki K; Tanaka E; Murayama T; Kuze F
Clin Exp Allergy; 1998 Feb; 28(2):233-40. PubMed ID: 9515598
[TBL] [Abstract][Full Text] [Related]
3. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
[TBL] [Abstract][Full Text] [Related]
4. Ratio of eosinophil cationic protein/eosinophil count as a new marker in children with acute asthma.
Imai C; Yamazaki H; Tanaka Y; Matsunaga M; Numata O; Torigoe K
Pediatr Int; 1999 Apr; 41(2):142-6. PubMed ID: 10221016
[TBL] [Abstract][Full Text] [Related]
5. The relationship of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma.
Prehn A; Seger RA; Faber J; Torresani T; Molinari L; Gerber A; Sennhauser FH
Pediatr Allergy Immunol; 1998 Nov; 9(4):197-203. PubMed ID: 9920218
[TBL] [Abstract][Full Text] [Related]
6. Significance of the eosinophil cationic protein/eosinophil count ratio in asthmatic patients: its relationship to disease severity.
Fujitaka M; Kawaguchi H; Kato Y; Sakura N; Ueda K; Abe Y
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):323-9. PubMed ID: 11289333
[TBL] [Abstract][Full Text] [Related]
7. The inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled corticosteroid dose in asthmatic patients.
Löwhagen O; Wever AM; Lusuardi M; Moscato G; De Backer WA; Gandola L; Donner CF; Ahlstedt S; Larsson L; Holgate ST
Respir Med; 2002 Feb; 96(2):95-101. PubMed ID: 11862965
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
[TBL] [Abstract][Full Text] [Related]
9. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma.
Wever AM; Wever-Hess J; Hermans J
Clin Exp Allergy; 1997 May; 27(5):519-29. PubMed ID: 9179426
[TBL] [Abstract][Full Text] [Related]
10. [Eosinophil cationic protein in patients with bronchial asthma].
Numao T; Fukuda T; Hirata A; Sagara H; Majima K; Nakajima H; Akutsu I; Ando N; Makino S
Arerugi; 1991 Feb; 40(2):93-9. PubMed ID: 1712583
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma.
Ferguson AC; Vaughan R; Brown H; Curtis C
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):23-8. PubMed ID: 7822660
[TBL] [Abstract][Full Text] [Related]
12. Eosinophil activity markers in peripheral blood have high predictive value for bronchial hyperreactivity in patients with suspected mild asthma.
Roquet A; Halldén G; Ihre E; Hed J; Zetterström O
Allergy; 1996 Jul; 51(7):482-8. PubMed ID: 8863925
[TBL] [Abstract][Full Text] [Related]
13. Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population.
Björnsson E; Janson C; Håkansson L; Enander I; Venge P; Boman G
Allergy; 1994 Oct; 49(9):730-6. PubMed ID: 7695062
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
Stelmach I; Jerzynska J; Kuna P
J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy.
Scher H; Berman D; Weinberg EG; Schinkel M; Peper B; Chalton DO; Potter PC
Clin Exp Allergy; 1996 Oct; 26(10):1131-41. PubMed ID: 8911698
[TBL] [Abstract][Full Text] [Related]
16. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
Chazan R; Grubek-Jaworska H; Hermanowicz-Salomon J; Droszcz W
Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
[TBL] [Abstract][Full Text] [Related]
17. Serum eosinophil cationic protein (ECP) as a mediator of inflammation in acute asthma, during resolution and during the monitoring of stable asthmatic patients treated with inhaled steroids according to a dose reduction schedule.
Kunkel G; Rydén AC
Inflamm Res; 1999 Feb; 48(2):94-100. PubMed ID: 10202995
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment.
Robinson DS; Assoufi B; Durham SR; Kay AB
Clin Exp Allergy; 1995 Nov; 25(11):1118-27. PubMed ID: 8581845
[TBL] [Abstract][Full Text] [Related]
19. Serum eosinophil cationic protein as a predictor of disease activity in acute and chronic asthma.
Onadeko BO; Khadadah ME; Mustafa HT; Ezeamuzie CI; Marouf R; Khamis A; Sugathan TN
East Afr Med J; 1999 Sep; 76(9):524-9. PubMed ID: 10685325
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil soluble protein levels, eosinophil peroxidase and eosinophil cationic protein in asthmatic patients.
Parra A; Sanz ML; Vila L; Prieto I; Diéguez I; Oehling AK
J Investig Allergol Clin Immunol; 1999; 9(1):27-34. PubMed ID: 10212854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
